PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Buvidal
Presentation Product Chemical substance Chapter Items dispensed
Buvidal 96mg/0.27ml prolonged-release inj pf syringes
0410030A0BGAFAT
Buvidal Buprenorphine hydrochloride Central Nervous System 2,705
Buvidal 64mg/0.18ml prolonged-release inj pf syringes
0410030A0BGAEAS
Buvidal Buprenorphine hydrochloride Central Nervous System 2,245
Buvidal 128mg/0.36ml prolonged-release inj pf syringes
0410030A0BGAGAU
Buvidal Buprenorphine hydrochloride Central Nervous System 1,613
Buvidal 24mg/0.48ml prolonged-release inj pf syringes
0410030A0BGACAQ
Buvidal Buprenorphine hydrochloride Central Nervous System 419
Buvidal 16mg/0.32ml prolonged-release inj pf syringes
0410030A0BGABAP
Buvidal Buprenorphine hydrochloride Central Nervous System 368
Buvidal 8mg/0.16ml prolonged-release inj pf syringes
0410030A0BGAAAN
Buvidal Buprenorphine hydrochloride Central Nervous System 235
Buvidal 160mg/0.45ml prolonged-release inj pf syringes
0410030A0BGAHAV
Buvidal Buprenorphine hydrochloride Central Nervous System 208
Buvidal 32mg/0.64ml prolonged-release inj pf syringes
0410030A0BGADAR
Buvidal Buprenorphine hydrochloride Central Nervous System 184

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.